Allarity Therapeutics (ALLR) Change in Account Payables (2020 - 2026)

Allarity Therapeutics (ALLR) has 7 years of Change in Account Payables data on file, last reported at -$47000.0 in Q1 2026.

• Quarterly Change in Account Payables fell 126.55% year-over-year to -$47000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 79.86% YoY) and the FY2025 annual result came in at -$1.1 million, up 72.27% from the prior year.
• Change in Account Payables advanced to -$47000.0 in Q1 2026, from -$1.6 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $5.0 million in Q1 2022 to a low of -$3.4 million in Q2 2024.
• A 5-year average of $181058.8 and a median of $139000.0 in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables surged 4562.96% — and 2024, when it tumbled 307.99%.
• Tracing ALLR's Change in Account Payables over 5 years: stood at $1.7 million in 2022, then gained by 20.01% to $2.1 million in 2023, then slumped by 123.44% to -$485000.0 in 2024, then sank by 224.12% to -$1.6 million in 2025, then jumped by 97.01% to -$47000.0 in 2026.
• The last three Change in Account Payables figures came in at -$47000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$3000.0 (Q3 2025), per Business Quant data.